Try our Advanced Search for more refined results
October 31, 2014
VELOSO v. APLIN et al
Case Number:
1:14-cv-01787
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 05, 2014
Endocyte Investor Sues Over Faulty Drug In $1B Merck Deal
Endocyte Inc.'s board of directors lied about an ineffective cancer drug at the heart of a $1 billion deal with Merck & Co. to inflate the company's stock ahead of a public offering, according to an investor's derivative suit recently filed in Indiana federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login